Literature DB >> 19672870

Percutaneous sclerotherapy of massive venous malformations of the face and neck using fibrin glue combined with OK-432 and pingyangmycin.

Wei-liang Chen1, Zhi-quan Huang, Da-ming Zhang, Qiang Chai.   

Abstract

BACKGROUND: Surgical excision is useful only for localized and limited lesions. The purpose of this study was to evaluate the clinical curative effect of percutaneous sclerotherapy of massive venous malformations of the face and neck using fibrin glue combined with OK-432 and pingyangmycin.
METHODS: Eighteen patients with massive venous malformations were treated with an injection of fibrin glue combined with OK-432 and pingyangmycin.
RESULTS: All the patients had extreme swelling postoperatively with no major complications. The follow-up period ranged from 6 to 12 months. Twelve lesions were completely involuted, 4 lesions were mostly involuted, and 2 lesions were partially involuted. All of the patients had normal liver and kidney functions. None of the patients presented with hematologic toxic effects or signs of pulmonary involvement.
CONCLUSION: Percutaneous sclerotherapy using fibrin glue combined with OK-432 and pingyangmycin provided a simple, safe, and reliable alternative treatment for massive venous malformations.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19672870     DOI: 10.1002/hed.21206

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  4 in total

1.  Science to practice: Can we expand focal interventional oncologic ablation treatments into an effective systemic therapy?

Authors:  S Nahum Goldberg
Journal:  Radiology       Date:  2013-05       Impact factor: 11.105

2.  Liquid nitrogen cryotherapy for lip mucous membrane venous malformation in infants.

Authors:  Da-Ming Zhang; You-Yuan Wang; Zhao-Yu Lin; Zhao-Hui Yang; Wei-Liang Chen
Journal:  Pediatr Surg Int       Date:  2014-12-02       Impact factor: 1.827

3.  Guidelines for the treatment of head and neck venous malformations.

Authors:  Jia Wei Zheng; Hua Ming Mai; Ling Zhang; Yan An Wang; Xin Dong Fan; Li Xin Su; Zhong Ping Qin; Yao Wu Yang; Yin Hua Jiang; Yi Fang Zhao; James Y Suen
Journal:  Int J Clin Exp Med       Date:  2013-05-22

4.  Chitosan-based liposomal thermogels for the controlled delivery of pingyangmycin: design, optimization and in vitro and in vivo studies.

Authors:  Ling Zhang; Fen Chen; Jiatong Zheng; Hongwei Wang; Xingjun Qin; Weisan Pan
Journal:  Drug Deliv       Date:  2018-11       Impact factor: 6.419

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.